[Interferon beta-1b. New therapy for patients with secondary progressive multiple sclerosis].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016899:Interferon-beta / Q000627:therapeutic use*; D008297:Male; D009103:Multiple Sclerosis / Q000276:immunology / Q000503:physiopathology* / Q000628:therapy
D000276:Adjuvants, Immunologic; D016899:Interferon-beta
Interferon beta-1b. Neue Therapie für Patienten mit sekundär progredienter Multipler Sklerose.